AC Immune
Joana Sousa is an experienced accounting professional currently serving as an AP Accountant at AC Immune since September 2020. Prior to this role, Joana completed a clerk internship at Ecole polytechnique fédérale de Lausanne from August 2015 to August 2016, which was part of the training to obtain a CFC in commercial employment and a professional maturity diploma. Joana holds a Bachelor's degree in Economic Law from HES-SO Haute école spécialisée de Suisse occidentale, obtained between 2016 and 2019, and completed secondary education at Gymnase de Chamblandes from 2013 to 2015.
AC Immune
3 followers
AC Immune SA is clinical-stage biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and NeuroOrphan indications driven by misfolded proteins. The Company’s two clinically validated technology platforms, SupraAntigen™ and Morphomer™, fuel its broad and diversified pipeline of first- and best-in-class assets, which currently features nine therapeutic and three diagnostic candidates, six of which are currently in clinical trials. AC Immune has a strong track record of securing strategic partnerships with leading global pharmaceutical companies including Genentech, a member of the Roche Group, Eli Lilly and Company, and Janssen Pharmaceuticals, Inc., resulting in substantial non-dilutive funding to advance its proprietary programs and >$3 billion in potential milestone payments.